Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07298369 · ClinicalTrials.gov registry record · NA

Cracking Consciousness Study With Monroe & Neuphoria (Cohort 2&3)

A NA study of Mental Health, sponsored by Efforia.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07298369 is a NA study of Mental Health that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, below the 10,182-participant average among 62 other Mental Health trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07298369, a NA study of Mental Health, is actively recruiting participants, sponsored by Efforia.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

In partnership with Monroe, this EEG neurofeedback study is looking at the efficacy of Neuphoria with Monroe for mental clarity and well-being.

Conditions Studied

Interventions

  • DEVICE Neuphoria Wearable

Study Locations (1)

New York

  • Efforia - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-09-25
Est. Completion 2026-09-25
Phase NA

Sponsor

Efforia

19 total trials

What the Registry Record Tells You About NCT07298369

The ClinicalTrials.gov registry entry for NCT07298369 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,182-participant average among 62 other Mental Health trials with a reported enrollment target (99% lower). The listed sponsor is Efforia, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mental Health appearing as the primary indexed condition, and to 1 intervention - of which Neuphoria Wearable is the first listed.

NCT07298369 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07298369 about?

NCT07298369 is a clinical study titled "Cracking Consciousness Study With Monroe & Neuphoria (Cohort 2&3)". In partnership with Monroe, this EEG neurofeedback study is looking at the efficacy of Neuphoria with Monroe for mental clarity and well-being.

What is the current status of trial NCT07298369?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-09-25. Estimated completion is 2026-09-25.

What conditions does trial NCT07298369 study?

This clinical trial studies the following conditions: Mental Health.

What interventions are being tested in trial NCT07298369?

The interventions under investigation include: Neuphoria Wearable (DEVICE).

Who is sponsoring clinical trial NCT07298369?

This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07298369 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.